Hunt Anthony

CIK 00016060303 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001606030

Recent Transactions

50 trades

Other
REPLIGEN CORP$RGEN
Common Stock
2025-12-04−2,000→ 98,959 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-13$151.01/sh−1,784→ 98,959 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-13$156.22/sh−5,737→ 82,699 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-13$152.17/sh−2,100→ 96,859 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2025-11-13+2,952→ 14,760 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2025-11-13$33.87/sh+2,952→ 83,695 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-13$154.32/sh−2,500→ 91,436 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-13$157.11/sh−1,956→ 80,743 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-13$155.45/sh−3,000→ 88,436 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-13$153.14/sh−2,923→ 93,936 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2025-11-12−25,000→ 157,344 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-12$158.51/sh−464→ 100,743 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2025-11-12$33.87/sh+25,000→ 125,743 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-12$158.01/sh−11,096→ 101,207 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-12$156.65/sh−4,959→ 112,303 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-12$154.92/sh−3,741→ 122,002 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-11-12$155.85/sh−4,740→ 117,262 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2025-09-10$33.87/sh+20,000→ 129,854 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-09-10$120.19/sh−14,882→ 110,506 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-09-10$119.64/sh−3,262→ 125,388 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2025-09-10−20,000→ 182,344 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-09-10$116.34/sh−96→ 129,758 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-09-10$122.23/sh−2,179→ 100,743 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-09-10$118.32/sh−1,108→ 128,650 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-09-10$121.42/sh−7,584→ 102,922 total
Award
908 Devices Inc.$MASS
Stock Option (option to buy)
2025-06-12+6,516→ 6,516 total
Award
908 Devices Inc.$MASS
Restricted Stock Units
2025-06-12+14,083→ 14,083 total
Exercise/Conversion
908 Devices Inc.$MASS
Restricted Stock Units
2025-06-11−11,364→ 0 total
Exercise/Conversion
908 Devices Inc.$MASS
Common Stock
2025-06-11+11,364→ 30,085 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-05-15$123.57/sh−17,596→ 116,662 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-05-15$125.20/sh−268→ 109,861 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-05-15$127.00/sh−7→ 109,854 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-05-15$122.66/sh−2,043→ 134,258 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-05-15$124.34/sh−6,533→ 110,129 total
Award
BIOLIFE SOLUTIONS INC$BLFS
Common Stock
2025-03-18+6,876→ 6,876 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2025-03-17−21,756→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2025-03-17$33.87/sh+5,000→ 141,301 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-03-17$151.09/sh−2,518→ 160,379 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2025-03-17$59.52/sh+21,756→ 163,057 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-03-17$150.38/sh−100→ 162,897 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-03-17$152.82/sh−15,619→ 138,584 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-03-17$153.70/sh−2,283→ 136,301 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-03-17$148.05/sh−60→ 162,997 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2025-03-17$151.96/sh−6,176→ 154,203 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2025-03-17−5,000→ 202,344 total
Tax Payment
REPLIGEN CORP$RGEN
Common Stock
2025-03-03$155.38/sh−10,142→ 136,301 total
Exercise/Conversion
908 Devices Inc.$MASS
Common Stock
2025-03-02+2,058→ 18,721 total
Exercise/Conversion
908 Devices Inc.$MASS
Restricted Stock Units
2025-03-02−2,058→ 0 total
Tax Payment
REPLIGEN CORP$RGEN
Common Stock
2025-02-27$156.54/sh−2,825→ 146,443 total
Tax Payment
REPLIGEN CORP$RGEN
Common Stock
2025-02-24$164.74/sh−2,380→ 149,268 total

Companies

Recent Filings

Address

C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100

WALTHAM, MA, 02453

View on SEC.gov